VALERIASMITHVALERIA SMITH0.000000000000000.000000000000004221SMITH, VALERIAAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:orcidIdORCID idvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonLeukemiaMD AndersonHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorELIAS JOSEPHJABBOURELIAS JOSEPH JABBOUR9124JABBOUR, ELIAS JOSEPHAssociate ProfessorGUILLERMOGARCIA-MANEROGUILLERMO GARCIA-MANERO8853GARCIA-MANERO, GUILLERMOProfessor74Professor10Assistant Professor14Associate Professor6Adjunct ProfessorJENNIFERFOSTERJENNIFER FOSTER0.000000000000000.000000000000005161FOSTER, JENNIFERAssociate Professor6701 FANNINHouston, 77030TX27586230Whittle SB, Patel K, Zhang L, Woodfield SE, Du M, Smith V, Zage PEInvestigational new drugsThe novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma. Invest New Drugs. 2016 12; 34(6):685-692.Invest New Drugs2016-09-01T00:00:002016The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma.28142287Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PEExpert review of anticancer therapyOverview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017 Apr; 17(4):369-386.Expert Rev Anticancer Ther2017-03-15T00:00:002017Overview and recent advances in the treatment of neuroblastoma.28759392Darby JB, Valentine G, Hillier K, Hunt R, Healy CM, Smith V, Allen-Rhoades WPediatricsA 3-Week-Old With an Isolated "Blueberry Muffin" Rash. Pediatrics. 2017 Jul; 140(1).Pediatrics2017-06-02T00:00:002017A 3-Week-Old With an Isolated "Blueberry Muffin" Rash.true1ProfessorProfessortrue1ProfessorProfessorD007155Chemicals & Drugs3746490.728414Immunologic FactorsD007167Procedures83233370.374536ImmunotherapyAuthorship 8906476Authorship 8906482Authorship 8906496true1Associate ProfessorAssociate ProfessorD010538Disorders73890.93978PeritonitisAuthorship 920400130154341Smith V, Foster JChildren (Basel, Switzerland)High-Risk Neuroblastoma Treatment Review. Children (Basel). 2018 Aug 28; 5(9).Children (Basel)2018-08-28T00:00:002018High-Risk Neuroblastoma Treatment Review.D016178Chemicals & Drugs1654090.861012Granulocyte-Macrophage Colony-Stimulating FactorD009447Disorders2546850.639021NeuroblastomaDepartment of PediatricsDepartment of SurgerySurgery-Pediatric Surgery DivPediatrics-OncologyBaylor College of MedicineNINORAINUSSONINO RAINUSSO0.000000000000000.000000000000001089RAINUSSO, NINOAssociate ProfessorJASONYUSTEINJASON YUSTEIN0.000000000000000.000000000000001413YUSTEIN, JASONAdjunct ProfessorJEDNUCHTERNJED NUCHTERN29.70731730000000-95.402264500000002018NUCHTERN, JEDProfessorDEBANANDAPATIDEBANANDA PATI0.000000000000000.000000000000003475PATI, DEBANANDAProfessorMOSTAFAGABERMOSTAFA GABER0.000000000000000.000000000000001569GABER, MOSTAFAProfessorZOANNDREYERZOANN DREYER0.000000000000000.000000000000002981DREYER, ZOANNProfessorSANJEEVVASUDEVANSANJEEV VASUDEVAN29.70731730000000-95.402264500000003804VASUDEVAN, SANJEEVAssociate Professor1.076810.0062612594research areas1.222220.036996557coauthor of12.71592.3693960similar to1117selected publicationstrue1Assistant ProfessorAssistant Professor31829069Silverstein A, Reddy K, Smith V, Foster JH, Russell HV, Whittle SBPediatric hematology and oncologyBlood product administration during high risk neuroblastoma therapy. Pediatr Hematol Oncol. 2020 Feb; 37(1):5-14.Pediatr Hematol Oncol2019-12-12T00:00:002019Blood product administration during high risk neuroblastoma therapy.SARAHWHITTLESARAH WHITTLE0.000000000000000.000000000000006432WHITTLE, SARAHAssociate ProfessorAuthorship 9858743Authorship 995688232729196Whittle SB, Smith V, Silverstein A, Parmeter M, Minard CG, Bernhardt MB, Zage PE, Venkatramani R, Nuchtern JG, Heczey A, Russell HV, Shohet JM, Foster JHPediatric blood & cancerIs high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.Pediatr Blood Cancer2020-07-30T00:00:002020Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.Authorship 996651332769559Whitlock RS, Malik T, Smith V, Mahajan P, Hayes-Jordan A, Vasudevan SAJournal of pediatric hematology/oncologySclerosing Encapsulating Peritonitis in a Pediatric Patient Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Pediatr Hematol Oncol. 2021 07 01; 43(5):e685-e688.J Pediatr Hematol Oncol2021-07-01T00:00:002021Sclerosing Encapsulating Peritonitis in a Pediatric Patient Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Authorship 998405632862510Orman G, Tran BH, Desai N, Meoded A, Kralik S, Smith V, Hicks J, Kirsch C, Huisman TAGMJournal of neuroimaging : official journal of the American Society of NeuroimagingNeuroimaging Characteristics of Nasopharyngeal Carcinoma in Children. J Neuroimaging. 2021 01; 31(1):137-143.J Neuroimaging2020-08-30T00:00:002020Neuroimaging Characteristics of Nasopharyngeal Carcinoma in Children.32930438Smith VR, Whittle SB, Coleman RD, Munoz FM, De Guzman MM, Foster JH, Navai SAPediatric blood & cancerSevere COVID-19 infection in a child receiving immunotherapy for cancer. Pediatr Blood Cancer. 2021 03; 68(3):e28710.Pediatr Blood Cancer2020-09-15T00:00:002020Severe COVID-19 infection in a child receiving immunotherapy for cancer.Authorship 1003326233089644Choe M, Smith V, Okcu MF, Wulff J, Gruner S, Huisman TAGM, Venkatramani RPediatric blood & cancerTreatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer. 2021 03; 68(3):e28778.Pediatr Blood Cancer2020-10-21T00:00:002020Treatment of central giant cell granuloma in children with denosumab.true1Associate ProfessorAssociate ProfessorAuthorship 1020061434061441Agarwal S, Mullikin D, Scheurer ME, Smith V, Naik-Mathuria B, Guillerman RP, Foster JH, Diaz R, Sartain SEPediatric blood & cancerRole of anticoagulation in the management of tumor thrombus: A 10-year single-center experience. Pediatr Blood Cancer. 2021 09; 68(9):e29173.Pediatr Blood Cancer2021-06-01T00:00:002021Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.true1Associate ProfessorAssociate Professor34224514Whitlock RS, Ebare K, Cheng LS, Fishman DS, Mills JL, Nguyen HN, Nuchtern JG, Ruan W, Smith VE, Patel KA, Fisher KE, Vasudevan SAJournal of pediatric hematology/oncologyAngiosarcoma of the Pancreas in a Pediatric Patient With an Activating KDR-Internal Tandem Duplication: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2022 Apr 01; 44(3):e751-e755.J Pediatr Hematol Oncol2022-04-01T00:00:002022Angiosarcoma of the Pancreas in a Pediatric Patient With an Activating KDR-Internal Tandem Duplication: A Case Report and Review of the Literature.Authorship 10260529Authorship 10260531true1ProfessorProfessorAuthorship 1035750534927531Williams AK, Gupta R, Patel KR, Marcogliese AN, Smith V, Dreyer ZEPediatric hematology and oncologyPhiladelphia chromosome-positive pre-B lymphoblastic leukemia presenting as acute hepatic failure in a pediatric patient. Pediatr Hematol Oncol. 2022 08; 39(5):481-487.Pediatr Hematol Oncol2021-12-19T00:00:002021Philadelphia chromosome-positive pre-B lymphoblastic leukemia presenting as acute hepatic failure in a pediatric patient.Authorship 1038025335262463Mahajan P, Navai S, Smith V, Potter S, Venkatramani RPediatric hematology and oncologyAdvancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board. Pediatr Hematol Oncol. 2022 10; 39(7):678-680.Pediatr Hematol Oncol2022-03-09T00:00:002022Advancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board.35237791Stubbs LA, Szafron V, Forbes LR, Musick MA, Gillispie AE, Sauer HE, Smith VR, Fasipe TA, Munoz FM, Tejtel KS, Silva-Carmona M, Vogel TP, Muscal EHospital pediatricsSevere Pediatric COVID-19 Pneumonia Treated With Adjuvant Anakinra. Hosp Pediatr. 2022 05 01; 12(5):e162-e170.Hosp Pediatr2022-05-01T00:00:002022Severe Pediatric COVID-19 Pneumonia Treated With Adjuvant Anakinra.Authorship 10476701435665495Desai AV, Applebaum MA, Karrison TG, Oppong A, Yuan C, Berg KR, MacQuarrie K, Sokol E, Hall AG, Pinto N, Wolfe I, Mody R, Shusterman S, Smith V, Foster JH, Nassin M, LaBelle JL, Bagatell R, Cohn SLCancerEfficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.Cancer2022-06-06T00:00:002022Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.Authorship 1047905835713195Scollon S, Eldomery MK, Reuther J, Lin FY, Potter SL, Desrosiers L, McClain KL, Smith V, Su JM, Venkatramani R, Hu J, Korchina V, Zarrin-Khameh N, Gibbs RA, Muzny DM, Eng C, Roy A, Parsons DW, Plon SEPediatric blood & cancerClinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 11; 69(11):e29859.Pediatr Blood Cancer2022-06-30T00:00:002022Clinical and molecular features of pediatric cancer patients with Lynch syndrome.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorAuthorship 10766387true1Adjunct ProfessorAdjunct Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorSHOBANAVAISHOBA NAVAI7435NAVAI, SHOBAAssistant ProfessorRAJKUMARVENKATRAMANIRAJKUMAR VENKATRAMANI7908VENKATRAMANI, RAJKUMAR0000-0002-4785-106XProfessor